Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,064 | 332 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $684.77 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $564.97 | 23 | $0 (2024) |
| PFIZER INC. | $534.78 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $523.07 | 27 | $0 (2024) |
| ABBVIE INC. | $458.66 | 29 | $0 (2024) |
| Amgen Inc. | $415.19 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $304.63 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $204.59 | 42 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $170.56 | 10 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $166.50 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,435 | 113 | AstraZeneca Pharmaceuticals LP ($278.08) |
| 2023 | $1,630 | 96 | PFIZER INC. ($280.09) |
| 2022 | $1,376 | 86 | Lilly USA, LLC ($188.16) |
| 2021 | $622.97 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($185.84) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 3,093 | 4,067 | $277,205 | $127,189 |
| 2022 | 37 | 3,421 | 4,483 | $286,949 | $138,096 |
| 2021 | 27 | 2,287 | 2,916 | $167,272 | $83,654 |
| 2020 | 11 | 419 | 440 | $27,361 | $13,524 |
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 424 | 649 | $58,410 | $32,965 | 56.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 325 | 453 | $59,796 | $32,892 | 55.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 172 | 203 | $15,225 | $10,106 | 66.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 85 | 97 | $17,460 | $9,012 | 51.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 374 | 585 | $6,435 | $4,906 | 76.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 27 | $5,400 | $3,446 | 63.8% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 44 | 47 | $6,580 | $3,234 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $4,500 | $3,053 | 67.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 286 | 401 | $14,837 | $3,048 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,020 | $2,905 | 48.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 127 | 146 | $10,804 | $2,489 | 23.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 218 | 291 | $11,931 | $2,411 | 20.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 29 | 30 | $2,490 | $1,863 | 74.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $1,530 | $1,477 | 96.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 120 | 132 | $6,732 | $1,366 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,431 | $1,271 | 52.3% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 29 | 29 | $2,320 | $997.31 | 43.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 54 | 56 | $4,312 | $921.76 | 21.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $900.00 | $841.50 | 93.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 20 | $1,220 | $631.62 | 51.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 28 | 28 | $2,184 | $621.92 | 28.5% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 14 | 14 | $1,960 | $538.58 | 27.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 24 | 25 | $2,500 | $503.88 | 20.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 31 | 37 | $2,368 | $485.44 | 20.5% |
| 74019 | X-ray of abdomen, 2 views | Office | 2023 | 16 | 22 | $1,716 | $471.03 | 27.4% |
About Meagan Hillhouse
Meagan Hillhouse is a Nurse Practitioner healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1013484864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meagan Hillhouse has received a total of $5,064 in payments from pharmaceutical and medical device companies, with $1,435 received in 2024. These payments were reported across 332 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,064).
As a Medicare-enrolled provider, Hillhouse has provided services to 9,220 Medicare beneficiaries, totaling 11,906 services with total Medicare billing of $362,464. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Houston, MS
- Active Since 10/30/2018
- Last Updated 10/30/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1013484864
Products in Payments
- JARDIANCE (Drug) $594.57
- MOUNJARO (Drug) $335.20
- NURTEC ODT (Drug) $313.35
- FARXIGA (Drug) $297.05
- EVENITY (Biological) $295.30
- UBRELVY (Drug) $293.55
- ELIQUIS (Drug) $239.88
- TRULICITY (Drug) $211.64
- XIFAXAN (Drug) $204.59
- BREZTRI (Drug) $172.37
- XARELTO (Drug) $170.56
- REXULTI (Drug) $166.50
- AREXVY (Drug) $149.40
- QULIPTA (Drug) $134.23
- Kerendia (Drug) $124.92
- SHINGRIX (Biological) $110.89
- PREVNAR 20 (Biological) $82.31
- AIRSUPRA (Drug) $80.28
- YUPELRI (Drug) $72.91
- Cologuard Collection Kit (Device) $72.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Houston
Melanie Frye, Np, NP
Nurse Practitioner — Payments: $213,174
Ms. Julie Weatherly, Np, NP
Nurse Practitioner — Payments: $69,991
Bianca Calo, Rn, Acnp, RN, ACNP
Nurse Practitioner — Payments: $32,043
Arby Cohen, Np, NP
Nurse Practitioner — Payments: $21,853
Elizabeth Bilsborough
Nurse Practitioner — Payments: $19,364
Rosa Rances, Msn, Aprn, Np-C, MSN, APRN, NP-C
Nurse Practitioner — Payments: $14,632